CVE-2026-16865

CVE-2026-16865 is a high-severity vulnerability in Ibm Vios with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM AIX 7.2, and 7.3 and IBM PowerVM VIOS 4.1 could allow a remote attacker to execute arbitrary code due to command injection.

Frequently asked questions

What is CVE-2026-16865?
IBM AIX 7.2, and 7.3 and IBM PowerVM VIOS 4.1 could allow a remote attacker to execute arbitrary code due to command injection.
How severe is CVE-2026-16865?
CVE-2026-16865 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2026-16865 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (78th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-16865?
CVE-2026-16865 primarily affects Ibm Vios. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2026-16865?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2026-16865 published?
CVE-2026-16865 was published on 2026-08-19 and last updated on 2026-08-22.

References

Affected products (2)

More vulnerabilities in Ibm Vios

All CVEs affecting Ibm Vios →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →